# FDA Inspection 1160347 - Cipla Limited - January 31, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/ff4028a6-ce64-4e10-9778-77c6252b51de/
Source feed: FDA_Inspections

> FDA Inspection 1160347 for Cipla Limited on January 31, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1160347
- Company Name: Cipla Limited
- Inspection Date: 2020-01-31
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1254500 - 2024-11-13](https://www.globalkeysolutions.net/api/records/fda_inspections/cipla-limited/50c6a772-2a7d-43d4-abfc-11aa6d3bc960/)
- [FDA Inspection 1254500 - 2024-11-13](https://www.globalkeysolutions.net/api/records/fda_inspections/cipla-limited/951ba987-ff08-4cf0-a68e-c3e82cccd492/)
- [FDA Inspection 1099619 - 2019-07-19](https://www.globalkeysolutions.net/api/records/fda_inspections/cipla-limited/87069a20-8238-4cd8-bfc5-d14eaee4db66/)
- [FDA Inspection 1009388 - 2017-04-05](https://www.globalkeysolutions.net/api/records/fda_inspections/cipla-limited/46b2399d-6408-40cd-82ae-4d8aac71506d/)
- [FDA Inspection 891868 - 2014-07-25](https://www.globalkeysolutions.net/api/records/fda_inspections/cipla-limited/77a61b51-34a6-439b-9d5e-906b15609e28/)

Company: https://www.globalkeysolutions.net/companies/cipla-limited/cefc1473-6852-4af7-b996-0730dc0834bb

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c